1. Home
  2. EMPD vs RPID Comparison

EMPD vs RPID Comparison

Compare EMPD & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Empery Digital Inc.

EMPD

Empery Digital Inc.

HOLD

Current Price

$3.31

Market Cap

101.2M

Sector

N/A

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$2.01

Market Cap

102.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMPD
RPID
Founded
2020
2006
Country
United States
United States
Employees
15
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.2M
102.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EMPD
RPID
Price
$3.31
$2.01
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
527.2K
241.6K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.78
EPS
N/A
N/A
Revenue
N/A
$33,587,000.00
Revenue This Year
$23.49
$19.12
Revenue Next Year
N/A
$18.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.74
52 Week Low
$3.19
$1.66
52 Week High
$11.37
$4.94

Technical Indicators

Market Signals
Indicator
EMPD
RPID
Relative Strength Index (RSI) 41.19 53.24
Support Level $3.19 $1.98
Resistance Level $4.98 $2.17
Average True Range (ATR) 0.21 0.15
MACD -0.00 0.01
Stochastic Oscillator 21.74 53.57

Price Performance

Historical Comparison
EMPD
RPID

About EMPD Empery Digital Inc.

Empery Digital Inc is an all-electric, off-road powersports vehicle company developing and building electric two and four-wheel motorcycles and utility terrain vehicles, also known as side-by-sides, along with a complete line of upgrades and accessories. The company's products include motorcycle and UTV products that are all-electric and designed for off-road use.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

Share on Social Networks: